发明名称 Permselective Membrane for Treating Vascular Calcifications in Chronic Hemodialysis Patients
摘要 The present disclosure relates to a hemodialysis membrane for the treatment of vascular calcification in hemodialysis patients, especially in chronic hemodialysis patients. The present disclosure further relates to methods of treating vascular calcification in hemodialysis patients, wherein the hemodialysis membrane is characterized in that it comprises at least one hydrophobic polymer and at least one hydrophilic polymer and in that it has a MWRO of between 15 and 20 kD and a MWCO of between 170-320 kD or that the hemodialysis membrane comprises at least one hydrophobic polymer and at least one hydrophilic polymer and has a MWRO of between 8.5 kD and 14.0 kD and a MWCO of between 55 kD and 130 kD.
申请公布号 US2015110887(A1) 申请公布日期 2015.04.23
申请号 US201414511329 申请日期 2014.10.10
申请人 Gambro Lundia AB 发明人 Storr Markus;Krause Bernd;Schindler Ralf;Zickler Daniel;Hegner Bjoern
分类号 A61M1/16;B01D61/24;A61K35/14 主分类号 A61M1/16
代理机构 代理人
主权项 1. A method of treating vascular calcification in a hemodialysis patient, comprising withdrawing and bypassing the blood from the patient in a continuous flow into contact with one face of a hemodialysis membrane, simultaneously passing dialysate solution in a continuous flow on an opposite face of the hemodialysis membrane to the side of the hemodialysis membrane in contact with the blood, the flow of the dialysate solution being countercurrent to the direction of flow of blood, and returning the blood into the patient, wherein the hemodialysis membrane comprises at least one hydrophobic polymer and at least one hydrophilic polymer and has a Molecular Weight Rejection Onset (MWRO) of between 15 and 20 kD and a Molecular Weight Cut-Off (MWCO) of between 170-320 kD as determined by dextran sieving before blood contact of the membrane.
地址 Lund SE